Background: This study aims to gather descriptions from multiethnic Asian breast cancer patients on their experiences and impact of chemotherapy-associated cognitive changes on their daily lives and their coping strategies.
Research has demonstrated that one's personal experience, including the culture in which one is raised, can have an impact on one's cognitive and social processes [8] . Crosscultural research has also demonstrated that cultural differences can influence episodic memory and cognitive correlates across ethnic groups [9] . Thus, there is a crucial need to evaluate the impact and psychosocial ramifications of cognitive changes in the words of Asian breast cancer patients.
In view of this research gap, this qualitative study was conducted to gather in-depth descriptions from multiethnic Asian breast cancer patients on their perception and experience of cognitive changes, impact on their family and working lives and their coping strategies. It is anticipated that results from this study will reflect Asian breast cancer patients' experiences with this phenomenon and provide directions for the amelioration of posttreatment quality of life in cancer survivors.
patients and methods design and participants
This is a qualitative study that involved focus group discussions. It was conducted at the National Cancer Centre Singapore (NCCS), the largest ambulatory cancer centre in Singapore. Participants were recruited based on the following inclusion criteria: (i) a diagnosis of breast cancer made by a medical oncologist, (ii) age >21 years, (iii) able to read and understand either English or Chinese and (iv) had completed or currently receiving chemotherapy treatment of breast cancer. Patients were excluded if they were unable to speak coherently and provide informed consent or if they had brain metastasis that might impair their judgment. Informed consent was obtained from participants and this study was approved by the SingHealth Institutional Review Board.
procedures Four English-speaking and four Chinese-speaking structured focus groups were conducted over a single day within the NCCS campus. This is configured to minimize the effects of priming [10] that could occur if the sessions were held on multiple days, as patients who participated in the earlier focus groups could have disseminated the discussion questions to other prospective participants who had yet to attend theirs.
Before the discussion, grouping of participants was based on (in the order of descending importance) preferred conversational language (English or Chinese), stage of breast cancer, last receipt of cancer treatment and education status. The focus group discussion was designed to be 60-80 min long. Each focus group consisted of four to six participants and was led by two English-speaking or Chinese-speaking trained facilitators who were psychosocial oncologists and medical social workers. They were also assisted by a note taker who was either a pharmacist or a research assistant.
Discussions were designed to utilize an open-ended approach. They proceeded from the most general to specific questions, thus minimizing the influence of probing by facilitators. Two training sessions were held before the focus group discussions to ensure consistency in the facilitation of the groups. In each session, facilitators would first gather their participants' unpleasant experiences with acute and delayed toxic effects of chemotherapy. Subsequently, the objectives of the focus group discussion were introduced and specific details about cognitive changes were gathered. At the end of the session, participants completed a brief self-administered questionnaire on: (i) their demographics information, (ii) their perception of the top five contributing factors of their cognitive changes and (iii) how receptive were they, from a scale of 1 to 10 ('1' being the least receptive and '10' being the most receptive), to receive chemotherapy if chemotherapyassociated neurocognitive toxicity was indeed scientifically proven. At the end of the session, participants were remunerated with a SGD$30 (USD$ 25) of grocery vouchers and complementary gifts from sponsors.
data analysis
Focus group discussions were voice recorded, transcribed verbatim and analyzed using thematic analysis [11] . Non-English transcripts were translated and reviewed by two bilingual research team members. The open-ended discussion guide and data-driven analytic methods adopted in this study were based on elements of the grounded theory [12] . From the data collected, key points were marked with a series of codes, which were extracted from the raw data. Codes that described similar manifestations were grouped into concepts and themes. In this study, two coders first familiarized themselves with the transcripts and met to generate initial codes independently. They met to discuss and reach a consensus on the codes. This process resulted in a final list of codes, which were used to code all the transcripts by a group of five research team members who reviewed each other's transcripts subsequently. Discrepancies were resolved using a consensus method. The codes were then collated into potential themes and reviewed by the research team to produce a description of the focus group findings. Qualitative analysis was conducted using the qualitative research software, Atlas.ti. Quantitative data were analyzed using SPSS, version 17.
results
A total of 128 invitation cards were distributed. Forty-three patients (response rate of 33.6%) participated in the study (supplemental Figure S1 , available at Annals of Oncology online). Majority of the participants were Chinese. The median age of the participants was 52 years old. Participants' employment and educational status varied widely across individuals. Majority of the participants were early-stage breast cancer patients who had completed their anthracycline-based chemotherapy within 12 months (Table 1 and supplemental  Table S1 , available at Annals of Oncology online).
A total of 74 open codes were created and categorized into three main broad themes: 'participants' experience with cognitive changes', 'impact of cognitive changes' and 'coping strategies'. A summary of the themes, subthemes and sample codes used in thematic analysis and representative quotes are presented in supplemental Table S2 (available at Annals of Oncology online).
experience with cognitive changes perception of the term 'chemobrain' and cognitive changes. The term 'chemobrain' or chemotherapy-associated cognitive issues were unfamiliar to most participants. It was observed that Chinese-speaking participants had difficulties comprehending the terms 'ren zhi gong neng' and 'hua liao nao' [13] (the Chinese equivalent of 'cognitive function' and 'chemobrain', respectively). Moderators needed to provide explanations and practical examples of cognitive function domains. Participants were rather averse to the term 'chemobrain', which had led to common misconceptions associated with this term. Some participants thought that 'chemobrain' referred to the metastasis of the breast cancer to the brain. Some participants viewed 'chemobrain' as a risk factor for dementia. Many participants, however, were able to identify the connection between chemotherapy and its adverse effects on brain cells. Participants also claimed that they were not warned by oncology practitioners on potential occurrence of cognitive changes of chemotherapy treatment.
Most participants experienced cognitive changes after receiving chemotherapy. Although participants acknowledged that they had experienced minor cognitive deficits before their breast cancer diagnosis, they agreed that their cognitive functioning had deteriorated after they had completed chemotherapy. However, a small group of participants claimed that they did not experience any cognitive changes while they were receiving chemotherapy. They suggested that the physical side-effects (such as numbness and vomiting) had overdominated the cognitive side-effects. Many could identify and articulate vividly their experiences once moderators provided minimal probing. Difficulties in concentration, memory, speech and language, decision making and learning new concepts or tasks were experienced by our participants (supplemental Table S3 , available at Annals of Oncology online). There was a lack of agreement on whether participants' cognitive function improved, remained the same or deteriorated after completion of chemotherapy. inconclusive. Many attributed this phenomenon to the physical adverse effects of chemotherapy, which led to mood changes, psychological disturbances and consequently, cognitive changes. This view had been mentioned across almost all focus groups.
Besides chemotherapy, other causes that were considered as contributing factors to cognitive changes included cancer-related fatigue, mood changes and lack of mental and physical activity (Figure 1 ). Participants agreed that chemotherapy, being 'toxic' and 'potent', could affect their brain cells but that should not be the sole cause. Participants perceived cancer-related fatigue or tiredness as a significant contributor to cognitive decline. They rationalized that whenever they were tired, they could not concentrate and could get distracted very easily. Mood changes, such as anxiety and depression, affected few participants mentally, emotionally and psychologically. During chemotherapy, participants faced treatment-related anxiety and psychological disturbances that might have compromise their cognitive functions.
impact of cognitive changes impact on family and working life. Discussion on the impact of cognitive changes to the family invited a wide range of responses from the participants. As Asians value communal living and kindred spirit, many participants expressed that their family members had provided them good psychosocial support. Patients claimed that their family members were forgiving and patient toward them.
However, a few participants conveyed that their spouses needed to be more understanding toward their conditions. Much of the negative impact on the family originated from their own expectations of themselves, as they were unable to fulfill their duties as mothers and wives in the family due to the cognitive deficits. Participants across all focus groups could vividly describe the impact of cognitive changes on their work life, regardless of their occupations. Although the consequences of the cognitive changes were negligible, these changes limited their working capabilities.
participants' emotional responses toward cognitive changes. Participants were anxious and frightened when they realized that they were unable to perform well, comparing to their prechemotherapy state. Some expressed embarrassment about these cognitive changes, which occurred during their daily interactions with colleagues and friends. A few participants mentioned that they had lost their confidence when they returned to work because they were not as mentally fit as they used to be.
Participants reported that if the existence of chemotherapyinduced neurocognitive toxicity was to be scientifically proven, it would not affect their willingness to accept chemotherapy treatment. Majority of participants (57.1%) assigned a receptivity score of 7-10, indicating that they were still very willing to receive chemotherapy. Only a minority (11.9%) revealed that the cognitive changes had disrupted their lives to the extent that they were resistant (score of 1-3) to chemotherapy. Participants adopted self-help strategies to prevent deterioration and cope with their cognitive changes ( Table 2) . Psychosocial management was the most commonly identified coping strategy. The importance of family support and engaging in communal activities such as cancer support groups surfaced through the discussion. Being a Chinese-dominated population, complementary alternative medicine (CAM), such as traditional Chinese medicine (TCM), was popular among participants [14] . Many believed that TCM, such as walnut and ginkgo extracts, helped to improve their alertness because TCM preserves their 'qi' or energy. Participants also claimed that physical and mental exercises can improve blood flow and oxygen to the brain. Chinese-speaking participants shared their experiences in practicing qi gong and playing mahjong, a mind-stimulating game that involves memory of tiles discarded by their opponents, fast reaction and flexibility of the mind to strategize their moves in order to win the game.
discussion
Qualitative results from our study showed that cognitive changes are highly relevant to Asian breast cancer patients. This is the first qualitative study that has examined the impact of chemotherapy-associated cognitive changes on Asian breast cancer patients. Thus far, there have not been any robust studies in the literature that have evaluated Asians' experience with the phenomenon of 'chemobrain'. It is alarming that the concept of this phenomenon is unfamiliar to most Asian cancer patients, yet cognitive changes have significantly impacted their daily lives.
Our results also emphasized the need to adopt a culturally relevant approach in the viewing of this phenomenon. It is evident that Asian breast cancer patients, especially those who were Chinese-speaking, were not familiar with the terms 'cognitive function' and 'chemobrain'. This is in contrast to what was observed in the focus groups studies conducted in the United States where participants had fewer problems in relating with these terms [15, 16] . Asian participants attributed this phenomenon to the physical adverse effects of chemotherapy, which led to mood changes, psychological disturbances and cognitive changes. This view is parallel to a well-received Asian's holistic approach to medicine, which interprets the well-being of humanity as a balance of body, mind and spirit [17] . Older married participants also expressed negative emotions associated with the impact of cognitive changes in their daily lives. Their recounts were reflective of typical Asian housewives whose conservative roles were to provide care and support for the spouse and children. Even though many had stated that their families empathized with them, participants still felt disappointed and guilty that they were not able to perform their duties at home up to their expectation. Reactions from Caucasian breast cancer patients of another focus group study were drastically different. They expressed that their negative emotions were inflicted from family members who 'did not take her complaints about her cognitive changes seriously' and challenged their authorities [15] . It can be reckoned from our results that patients' cultural experiences are important in the understanding of the nature and impact of this phenomenon. Cross-cultural adaptation is hence an important process in the development and translation of subjective neuropsychological tools and cognitive-related quality-of-life instruments.
Similar to the results obtained from another focus group study conducted among Caucasian breast cancer population, participants were not aware of this potential adverse effect before they received chemotherapy [15] . One study highlighted that a majority of the interviewed breast cancer women complained a lack of acknowledgement by the medical community when they described their cognitive disturbances [15] . Participants also expressed that they were too overwhelmed by the physical sideeffects of chemotherapy that they were oblivious to the cognitive changes. Our results revealed that patients were likely to be aware of the impact of those cognitive changes, rather than the change itself. Therefore, the impact of the cognitive impairment became apparent only when they experienced limitations in their daily functioning after they had completed chemotherapy. These findings reflect that cancer patients require different specialized forms of supportive care at various stages of their cancer treatment. The challenge lies ahead in the provision of a comprehensive and holistic supportive care plan that addresses not just the management of physical symptoms but also cognitive, psychosocial and spiritual aspects. One example of an instrument that is currently undergoing validation to detect psychological disturbances in cancer patients is the 'distress thermometer' [18] . Our results have also reinforced the importance to incorporate patients' reported outcomes into cognitive studies for cancer patients. The International Cognition and Cancer Task Force recently gave a recommendation on objective neuropsychological tools [19] . Currently, widely used subjective tools such as the Cognitive Failure Questionnaire [20] and Functional Assessment of Cancer Therapy Cognitive [21] are deficient to address all cognitive domains, have limited psychometrics data or have not been validated within the cancer population. Further harmonization and validation studies are needed to bridge this research gap.
Despite the awareness of the potential neurocognitive adverse effects, majority of participants indicated that they are still receptive to chemotherapy and are amenable to coping strategies of their cognitive changes. Usage of CAM [14] and psychosocial interventions are popular among Asian cancer patients. Several culturally related solutions were extensively utilized by our Chinese participants. It is worthwhile to note that Asian participants valued the benefits that CAM, qi gong and mahjong may bring to their health. Chinese participants believed that usage of CAM and practicing qi gong can improve their 'qi' (energy) and blood circulation to the brain. A recent study suggested that cancer patients who practiced medical qi gong had statistically better self-reported cognitive function, quality of life and reduced levels of C-reactive protein inflammatory marker as compared with controls [22] . Another study showed that playing mahjong produced consistent gains across cognitive performance measures and on the MiniMental Status Examination [23] . A review of studies of mindfulness therapy in oncology had documented its potential for improving mood, fatigue, psychological functioning and enhanced well-being in cancer patients [24] . Participants were unfavorable to pharmacological options or 'Western medications'. Moreover, polypharmacy in oncology has been associated with nonadherence, drug interactions and adverse reactions [25, 26] . Oncologists and pharmacists play an important role in the management of chemotherapy-associated symptoms experienced by cancer patients. Studies had revealed that psychosocial and psychological distress experienced by patients were often undetected [27, 28] . Therefore, future research may be steered toward conducting well-designed randomized controlled trials in the evaluation of nonpharmacological management of cognitive changes.
limitations
This study had a few limitations. Selection bias might exist as breast cancer patients were recruited from a nonrandomized sample and the response rate was considerably low. Baseline assessment of patients' cognitive function was not conducted. The focus groups also contained participants with heterogeneous cancer treatment status. The objective of the study was briefly made known to participants when they provided informed consent. Therefore, participants might have been predisposed to the priming effects and preexisting knowledge of chemobrain [10] . However, given that this was an exploratory qualitative investigation, we feel that these shortcomings were acceptable and should not pose major compromises in our findings.
conclusions
The term 'chemobrain' is unfamiliar to most Asian cancer patients but post-chemotherapy cognitive changes have significantly impacted their family and working lives. There is evidence that cognitive disturbances can differ among ethnic groups. Well-designed epidemiological studies are needed to quantify the prevalence, severity and impact of this problem in Asia. Our results suggested that a culturally relevant approach, including cultural adaptation of subjective neuropsychological tools and implementation of culturally accepted coping strategies, should be adopted to evaluate and manage perceived cognitive changes in these patients.
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